| Literature DB >> 15866765 |
Susan S Schiffman1, Clare E Studwell, Lawrence R Landerman, Katherine Berman, John S Sundy.
Abstract
Aerial emissions from a swine house at North Carolina State University's field laboratory were diluted to a level that could occur at varying distances downwind from a confined animal feeding operation (CAFO) both within and beyond the property line, and these emissions were delivered to an environmental exposure chamber. The study design consisted of two 1-hr sessions, one in which 48 healthy human adult volunteers were exposed to diluted swine air and another in which they were exposed to clean air (control). Objective measures of blood pressure, temperature, heart rate, respiratory rate, lung function, nasal inflammation, secretory immunity, mood, attention, and memory were correlated with objective measures of air quality. Ratings of perceived (self-reported) health symptoms were also obtained. The mean levels of airborne constituents in the swine air condition were hydrogen sulfide (24 ppb), ammonia (817 ppb), total suspended particulates (0.0241 mg/m3), endotoxin (7.40 endotoxin units/m3), and odor (57 times above odor threshold). No statistical differences on objective measures of physical symptoms, mood, or attention resulted from the 1-hr exposure to swine emissions in the environmental chamber when compared with clean air for healthy human volunteers. However, subjects were 4.1 (p = 0.001) times more likely to report headaches, 6.1 (p = 0.004) times more likely to report eye irritation, and 7.8 (p = 0.014) times more likely to report nausea in the swine air (experimental) condition than in the control condition. These results indicate that short-term exposure in an environmental chamber to malodorous emissions from a swine house at levels expected downwind can induce clinically important symptoms in healthy human volunteers.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15866765 PMCID: PMC1257549 DOI: 10.1289/ehp.6814
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Exposure facility. Reprinted from Bottcher et al. 2002 with permission.
Mean levels of the H2S, ammonia, particulates, endotoxin, and odor in the two conditions along with the instruments used for air quality measurements.
| Emission | Instrument used for measurement | Control condition | Experimental condition |
|---|---|---|---|
| H2S | Jerome meter | 0 ppb | 24 ppb |
| Ammonia | Chemiluminescence analyzer | 46.4 ppb | 817 ppb |
| Total suspended particulates | HAZ-DUST | 0.0136 mg/m3 | 0.0241 mg/m3 |
| Endotoxin | LAL assay | 0.63 EU/m3 | 7.40 EU/m3 |
| Odor | Scentometer and nasal ranger | 0.3 D/T | 56 D/T |
| Odor | AC’SCENT olfactometer | — | 57 D/T |
D/T (dilutions to threshold) indicates the dilution ratio at which the sample has a probability of 0.5 of being detected under the conditions of the test.
Timelines for physiologic and psychological measurements.
| Just before exposure | 30 min into exposure | 1 hr (end of exposure) | 2 hr after end of exposure |
|---|---|---|---|
| Vital signs | Vital signs | Vital signs | |
| Spirometry | Spirometry | ||
| Nasal lavage | Nasal lavage | ||
| Salivary IgA | Salivary IgA | ||
| Mood | Mood | Mood | Mood |
| Attention and memory | Attention and memory | Attention and memory | Attention and memory |
| Odor ratings | Odor ratings | Odor ratings | |
| EEHQ | EEHQ | EEHQ |
EEHQ, Environmental Exposures and Health Questionnaire.
Blood pressure, temperature, heart rate, respiratory rate.
The 30 feelings that were rated on the POMS.
| Tense | Unworthy | Gloomy |
| Angry | Uneasy | Sluggish |
| Worn out | Fatigued | Weary |
| Lively | Annoyed | Bewildered |
| Confused | Discouraged | Furious |
| Shaky | Nervous | Efficient |
| Sad | Lonely | Full of pep |
| Active | Muddled | Bad tempered |
| Grouchy | Exhausted | Forgetful |
| Energetic | Anxious | Vigorous |
The 48 symptoms on the EEHQ.
| Hives, itching skin | Feeling angry, irritable | Feeling anxious, panicky |
| Skin rash | Feeling depressed | Wheeze, chest tightness |
| Skin redness, flushing | Eyes dry, irritated | Shortness of breath |
| Feeling feverish, chills | Tearing eyes | Chest pain |
| Migraine headache | Blurred vision | Heart racing, pounding |
| Sinus headache | Sinus/nasal congestion | Difficulty breathing |
| Other headache | Nasal secretions | Cough |
| “Spacy” feeling | Nasal irritation, burning | Cough up sputum, phlegm |
| Brain fog | Difficulty concentrating | Hoarseness |
| Cold hands or feet | Memory problems | Nausea |
| Throat sore, irritated | Inappropriate emotions | Vomiting |
| Throat itching inside | Ear redness, flushing | Diarrhea |
| Coordination problems | Ears itching inside | Abdominal bloating, pain |
| Muscle weakness | Daytime sleepiness | Constipation |
| Muscle aches, joint pain | Undue fatigue | Heartburn |
| Numbness of legs, arms | Trembling, body shaking | Pelvic pain |
Results of significance testing for effects of exposure on change in an outcome (effect coefficients are given for significant effects only).
| Group differences on time 2 – time 1 change
| |||
|---|---|---|---|
| Coefficient | |||
| Vital signs | |||
| Heart rate | 0.78 | ||
| Respiratory rate | 0.57 | ||
| Temperature | 0.27 | ||
| Systolic blood pressure | 0.70 | ||
| Diastolic blood pressure | 0.29 | ||
| Blood pressure ratio (systolic to diastolic) | 0.52 | ||
| Spirometry | |||
| Percent change FEV1 | 0.98 | ||
| Percent change FVC | 0.80 | ||
| Percent change FEF 25–75% | 0.88 | ||
| Salivary measure | |||
| Salivary IgA (μg/mL) | 0.57 | ||
| Mood scores (POMS) | |||
| Anger | 0.97 | ||
| Confusion | 0.83 | ||
| Depression | 0.45 | ||
| Fatigue | 0.52 | ||
| Anxiety | 0.39 | ||
| Vigor | 0.52 | ||
| Total mood | 0.55 | ||
| Digit span test | |||
| Digit span score | 0.35 | ||
| Nasal lavage | |||
| IL-8 (pg/mL) | 0.11 | ||
| IL-1β(pg/mL) | 0.38 | ||
| Cell counts | 0.76 | ||
| Percent epithelial cells | 0.02 | (b = −21.1) | — |
| Percent lymphocytic cells | 0.008 | (b = 23.0) | — |
| Percent PMNs | 0.22 | ||
| Absolute epithelial cells | 0.15 | ||
| Absolute lymphocytic cells | 0.78 | ||
| Absolute PMNs | 0.27 | ||
| Self-reported symptoms | |||
| Headache | 0.001 | (OR = 4.1) | 0.01 |
| Sore throat | 0.27 | ||
| Itchy throat | 0.12 | ||
| Eyes irritated | 0.004 | (OR = 6.1) | 0.07 |
| Eyes tearing | — | ||
| Nasal congestion | 0.76 | ||
| Nasal secretion | 0.22 | ||
| Nasal irritation | 0.34 | ||
| Difficulty breathing | — | ||
| Cough | 0.66 | ||
| Nausea | 0.014 | (OR = 7.8) | 0.57 |
The p-value for time 3 is based on a test of whether the (time 2 – time 1) group differences persist at time 3. The time 3 test was performed only when group differences on (time 2 – time 1) were statistically significant.
The b-coefficient obtained from SAS PROC MIXED represents the metric effect of exposure on an outcome at time 2 controlling for period and preexposure (time 1) differences.
No time 3 measures were obtained for these outcomes.
The odds ratio (OR) coefficient estimated with SAS PROC GENMOD is the exponentiated logistic effect of exposure on the odds of any symptom at time 2 controlling for period and preexposure differences.
Model did not converge because of low prevalence at time 2.
Means ± SDs for vital signs, salivary measures, nasal lavage, pulmonary function, and the digit span test over time.
| Condition | Before exposure | 1 hr (end of exposure) | 2 hr after end of exposure | |
|---|---|---|---|---|
| Vital signs | ||||
| Heart rate | Experimental | 70.85 ± 14.61 | 65.02 ± 13.36 | 65.79 ± 11.95 |
| Control | 69.96 ± 11.49 | 64.73 ± 13.39 | 64.81 ± 12.07 | |
| Respiratory rate | Experimental | 17.50 ± 4.24 | 17.25 ± 3.86 | 16.63 ± 4.84 |
| Control | 17.04 ± 3.67 | 16.75 ± 3.19 | 16.88 ± 3.25 | |
| Temperature | Experimental | 97.97 ± 0.74 | 97.85 ± 0.64 | 97.63 ± 0.50 |
| Control | 97.83 ± 0.61 | 97.72 ± 0.66 | 97.57 ± 0.58 | |
| Systolic blood pressure | Experimental | 122.27 ± 15.27 | 120.44 ± 15.67 | 123.88 ± 14.61 |
| Control | 121.63 ± 15.32 | 119.73 ± 14.72 | 121.85 ± 15.35 | |
| Diastolic blood pressure | Experimental | 66.44 ± 10.23 | 66.33 ± 10.02 | 67.52 ± 11.42 |
| Control | 64.15 ± 10.71 | 65.33 ± 10.60 | 69.13 ± 9.62 | |
| Nasal lavage | ||||
| IL-8 (pg/mL) | Experimental | 396.1 ± 448.4 | NA | 190.6 ± 213.0 |
| Control | 385.0 ± 321.7 | NA | 268.4 ± 310.2 | |
| IL-1β(ng/mL) | Experimental | 10.6 ± 21.8 | NA | 3.5 ± 8.3 |
| Control | 4.6 ± 6.5 | NA | 4.6 ± 10.3 | |
| Cell counts | Experimental | 205541.7 ± 442500.2 | NA | 240364.6 ± 505983.6 |
| Control | 146937.5 ± 332148.5 | NA | 277354.2 ± 1155336.9 | |
| Percent epithelial cells | Experimental | 55.6 ± 38.1 | NA | 35.7 ± 35.6 |
| Control | 67.2 ± 40.1 | NA | 56.7 ± 40.6 | |
| Percent lymphocytic cells | Experimental | 44.1 ± 38.0 | NA | 64.9 ± 35.6 |
| Control | 32.6 ± 40.2 | NA | 42.0 ± 41.5 | |
| Percent PMNs | Experimental | 0.1 ± 0.5 | NA | 0.0 ± 0.3 |
| Control | 0.0 ± 0.0 | NA | 1.2 ± 6.0 | |
| Salivary measures | ||||
| Salivary IgA (μg/mL) | Experimental | 193.42 ± 112.17 | 191.94 ± 116.57 | NA |
| Control | 194.68 ± 120.39 | 179.89 ± 116.88 | NA | |
| Pulmonary function | ||||
| Percent change FEV1 | Experimental | NA | 0.02 ± 0.04 | NA |
| Control | NA | 0.00 ± 3.31 | NA | |
| Percent change FVC | Experimental | NA | 0.05 ± 0.03 | NA |
| Control | NA | −0.13 ± 3.78 | NA | |
| Percent change FEF 25–75% | Experimental | NA | 1.02 ± 0.12 | NA |
| Control | NA | 0.78 ± 7.63 | NA | |
NA, not applicable.
Means ± SDs for scores on POMS at four time points.
| Group | Mood scale | Just before exposure | 30 min into exposure | 1 hr (end of exposure) | 2 hr after end of exposure |
|---|---|---|---|---|---|
| Experimental | Anger–hostility | 0.96 ± 1.86 | 1.42 ± 2.86 | 1.35 ± 3.27 | 0.94 ± 2.15 |
| Confusion–bewilderment | 3.19 ± 1.83 | 3.79 ± 2.26 | 4.19 ± 2.47 | 3.60 ± 1.87 | |
| Depression–dejection | 0.83 ± 1.72 | 1.10 ± 2.43 | 1.02 ± 2.34 | 0.69 ± 1.69 | |
| Fatigue–inertia | 3.21 ± 3.96 | 4.79 ± 3.83 | 5.13 ± 4.29 | 4.15 ± 4.44 | |
| Tension–anxiety | 1.94 ± 2.93 | 1.73 ± 2.52 | 1.29 ± 2.20 | 0.79 ± 1.58 | |
| Vigor–activity | 8.27 ± 4.74 | 3.60 ± 3.75 | 3.29 ± 3.35 | 3.79 ± 3.87 | |
| Total mood score | 1.85 ± 11.71 | 9.23 ± 12.55 | 9.69 ± 12.56 | 6.38 ±10.80 | |
| Control | Anger–hostility | 0.50 ± 1.46 | 1.00 ± 2.79 | 0.94 ± 2.68 | 1.17 ± 3.14 |
| Confusion–bewilderment | 2.75 ± 1.45 | 3.48 ± 1.84 | 3.52 ± 1.82 | 3.46 ± 1.56 | |
| Depression–dejection | 0.65 ± 1.59 | 1.08 ± 2.36 | 0.58 ± 1.61 | 0.62 ± 1.79 | |
| Fatigue–inertia | 3.10 ± 4.55 | 4.38 ± 4.67 | 4.15 ± 4.83 | 4.08 ± 4.66 | |
| Tension–anxiety | 1.48 ± 2.10 | 1.23 ± 2.10 | 0.83 ± 2.12 | 0.92 ± 2.22 | |
| Vigor–activity | 7.98 ± 5.50 | 3.73 ± 4.03 | 3.54 ± 3.67 | 3.52 ± 3.92 | |
| Total mood score | 0.50 ± 11.44 | 7.44 ± 12.68 | 6.48 ± 11.43 | 6.73 ±11.65 |
Means ± SDs for scores on the digit span test at four time points.
| Just before exposure | 30 min into exposure | 1 hr (end of exposure) | 2 hr after end of exposure | |
|---|---|---|---|---|
| Experimental | 6.92 ± 1.30 | 6.90 ± 1.34 | 7.33 ± 1.40 | 7.46 ± 1.20 |
| Control | 6.92 ± 1.40 | 7.08 ± 1.25 | 7.46 ± 1.11 | 7.31 ± 1.36 |
Number of persons self-reporting symptoms.
| Experimental
| Control
| |||||
|---|---|---|---|---|---|---|
| Symptom | Just before exposure | 1 hr (end of exposure) | 2 hr after end of exposure | Just before exposure | 1 hr (end of exposure) | 2 hr after end of exposure |
| Total headaches combined (migraine, sinus, other) | 4 | 23 | 15 | 5 | 10 | 6 |
| Eyes dry, irritated | 2 | 11 | 7 | 2 | 3 | 2 |
| Nausea | 0 | 12 | 1 | 0 | 2 | 2 |
| Throat sore, irritated | 2 | 9 | 3 | 3 | 6 | 5 |
| Throat itching inside | 0 | 6 | 3 | 0 | 2 | 2 |
| Tearing eyes | 1 | 1 | 1 | 0 | 1 | 2 |
| Sinus/nasal congestion | 6 | 5 | 5 | 7 | 6 | 6 |
| Nasal secretions | 3 | 1 | 3 | 4 | 4 | 3 |
| Nasal irritation, burning | 0 | 1 | 2 | 0 | 3 | 1 |
| Difficulty breathing | 0 | 1 | 2 | 0 | 0 | 1 |
| Cough | 4 | 6 | 2 | 4 | 5 | 3 |